central and peripheral glp 1 systems independently suppress eating Potential mechanisms of weight loss caused by the effects of GLP‐1 Mechanisms of GLP-1 Receptor Agonist-Induced

Standard subcutaneous dose: 1.25 to 2 mg, 45 to 60 minutes before anticipated activity

No published study has shown BPC-157 causes cancer in humans or animals, and some preclinical work even suggests anti-tumor activity in certain models, but the mechanism means caution is warranted rather than dismissed

BSO treatment was performed similarly as for ITCs by adding it (100 mM stock solution prepared in water) to the medium (either on its own or in combination with ITC) to obtain BSO concentrations ranging from 50 M to 700 M

BPC is considered a synthetic peptide because this particular substance is created synthetically in a lab